[HTML][HTML] Gefitinib or erlotinib as maintenance therapy in patients with advanced stage non-small cell lung cancer: a systematic review

X Chen, Y Liu, OD Røe, Y Qian, R Guo, L Zhu, Y Yin… - PloS one, 2013 - journals.plos.org
Background Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKI),
gefitinib and erlotinib have been tested as maintenance therapy in patients with advanced …

[PDF][PDF] Gefitinib or Erlotinib as Maintenance Therapy in Patients with Advanced Stage Non-Small Cell Lung

X Chen, Y Liu, OD Røe, Y Qian, R Guo - 2013 - pdfs.semanticscholar.org
Background: Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKI),
gefitinib and erlotinib have been tested as maintenance therapy in patients with advanced …

Gefitinib or Erlotinib as Maintenance Therapy in Patients with Advanced Stage Non-Small Cell Lung Cancer: A Systematic Review

X Chen, Y Liu, OD Røe, Y Qian, R Guo, L Zhu… - PLOS …, 2013 - econpapers.repec.org
Background: Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKI),
gefitinib and erlotinib have been tested as maintenance therapy in patients with advanced …

[引用][C] Gefitinib or Erlotinib as Maintenance Therapy in Patients with Advanced Stage Non-Small Cell Lung Cancer: A Systematic Review

X Chen, Y Liu, OD Røe, Y Qian, R Guo, L Zhu… - PLoS …, 2013 - ui.adsabs.harvard.edu
Gefitinib or Erlotinib as Maintenance Therapy in Patients with Advanced Stage Non-Small Cell
Lung Cancer: A Systematic Review - NASA/ADS Now on home page ads icon ads Enable full …

[引用][C] Gefitinib or Erlotinib as Maintenance Therapy in Patients with Advanced Stage Non-Small Cell Lung Cancer: A Systematic Review

X Chen, Y Liu, OD Røe, Y Qian, R Guo, L Zhu, Y Yin… - PLoS ONE, 2013 - cir.nii.ac.jp
Gefitinib or Erlotinib as Maintenance Therapy in Patients with Advanced Stage Non-Small
Cell Lung Cancer: A Systematic Review | CiNii Research CiNii 国立情報学研究所 学術情報 …

Gefitinib or Erlotinib as Maintenance Therapy in Patients with Advanced Stage Non-Small Cell Lung Cancer: A Systematic Review

X Chen, Y Liu, OD Roe, Y Qian, R Guo, L Zhu, Y Yin… - PLoS ONE, 2013 - go.gale.com
Current recommendations for chemotherapy treatment of patients with advanced non-small
cell lung cancer (NSCLC) are four to six cycles as more cycles do not provide a survival …

Gefitinib or Erlotinib as Maintenance Therapy in Patients with Advanced Stage Non-Small Cell Lung Cancer: A Systematic Review.

X Chen, Y Liu, OD Røe, Y Qian, R Guo, L Zhu… - PLoS …, 2013 - search.ebscohost.com
Background: Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKI),
gefitinib and erlotinib have been tested as maintenance therapy in patients with advanced …

Gefitinib or erlotinib as maintenance therapy in patients with advanced stage non-small cell lung cancer: a systematic review.

X Chen, Y Liu, OD Røe, Y Qian, R Guo, L Zhu, Y Yin… - Plos one, 2013 - europepmc.org
Background Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKI),
gefitinib and erlotinib have been tested as maintenance therapy in patients with advanced …

Gefitinib or erlotinib as maintenance therapy in patients with advanced stage non-small cell lung cancer: a systematic review

X Chen, Y Liu, OD Røe, Y Qian, R Guo, L Zhu, Y Yin… - PLOS ONE, 2013 - vbn.aau.dk
BACKGROUND: Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKI),
gefitinib and erlotinib have been tested as maintenance therapy in patients with advanced …

Gefitinib or Erlotinib as Maintenance Therapy in Patients with Advanced Stage Non-Small Cell Lung Cancer: A Systematic Review

X Chen, Y Liu, OD Røe, Y Qian, R Guo, L Zhu, Y Yin… - PLOS ONE, 2013 - ideas.repec.org
Background: Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKI),
gefitinib and erlotinib have been tested as maintenance therapy in patients with advanced …